203 related articles for article (PubMed ID: 12834252)
1. Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease.
Engelborghs S; Marescau B; De Deyn PP
Neurochem Res; 2003 Aug; 28(8):1145-50. PubMed ID: 12834252
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid amino compounds in Parkinson's disease. Alterations due to carbidopa/levodopa.
Manyam BV; Ferraro TN; Hare TA
Arch Neurol; 1988 Jan; 45(1):48-50. PubMed ID: 3337677
[TBL] [Abstract][Full Text] [Related]
3. Monoamine metabolism in the cerebrospinal fluid in Parkinson's disease: relationship to clinical symptoms and subsequent therapeutic outcomes.
Tohgi H; Abe T; Takahashi S; Takahashi J; Nozaki Y; Ueno M; Kikuchi T
J Neural Transm Park Dis Dement Sect; 1993; 5(1):17-26. PubMed ID: 8094960
[TBL] [Abstract][Full Text] [Related]
4. Decreased cerebrospinal fluid levels of neutral and basic amino acids in patients with Parkinson's disease.
Molina JA; Jiménez-Jiménez FJ; Gomez P; Vargas C; Navarro JA; Ortí-Pareja M; Gasalla T; Benito-León J; Bermejo F; Arenas J
J Neurol Sci; 1997 Sep; 150(2):123-7. PubMed ID: 9268238
[TBL] [Abstract][Full Text] [Related]
5. Changes in the concentration of amino acids in serum and cerebrospinal fluid of patients with Parkinson's disease.
Mally J; Szalai G; Stone TW
J Neurol Sci; 1997 Oct; 151(2):159-62. PubMed ID: 9349670
[TBL] [Abstract][Full Text] [Related]
6. Alteration of amino acids in cerebrospinal fluid from patients with Parkinson's disease and spinocerebellar degeneration.
Araki K; Takino T; Ida S; Kuriyama K
Acta Neurol Scand; 1986 Feb; 73(2):105-10. PubMed ID: 3705920
[TBL] [Abstract][Full Text] [Related]
7. Milacemide effects on the temporal inter-relationship of amino acids and monoamine metabolites in rat cerebrospinal fluid.
Semba J; Patsalos PN
Eur J Pharmacol; 1993 Jan; 230(3):321-6. PubMed ID: 8440309
[TBL] [Abstract][Full Text] [Related]
8. Monoamines and their metabolites in plasma and lumbar cerebrospinal fluid of Chinese patients with Parkinson's disease.
Chia LG; Cheng FC; Kuo JS
J Neurol Sci; 1993 Jun; 116(2):125-34. PubMed ID: 8336158
[TBL] [Abstract][Full Text] [Related]
9. The effect of age on concentrations of monoamines, amino acids, and their related substances in the cerebrospinal fluid.
Tohgi H; Takahashi S; Abe T
J Neural Transm Park Dis Dement Sect; 1993; 5(3):215-26. PubMed ID: 8369101
[TBL] [Abstract][Full Text] [Related]
10. The significance of 3-O-methyldopa concentrations in the cerebrospinal fluid in the pathogenesis of wearing-off phenomenon in Parkinson's disease.
Tohgi H; Abe T; Kikuchi T; Takahashi S; Nozaki Y
Neurosci Lett; 1991 Oct; 132(1):19-22. PubMed ID: 1787913
[TBL] [Abstract][Full Text] [Related]
11. Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease.
Poceta JS; Parsons L; Engelland S; Kripke DF
Sleep Med; 2009 Jan; 10(1):129-33. PubMed ID: 18207455
[TBL] [Abstract][Full Text] [Related]
12. A significant reduction of putative transmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease and spinocerebellar degeneration.
Tohgi H; Abe T; Hashiguchi K; Takahashi S; Nozaki Y; Kikuchi T
Neurosci Lett; 1991 May; 126(2):155-8. PubMed ID: 1681472
[TBL] [Abstract][Full Text] [Related]
13. Free amino acids in the cerebrospinal fluid in old age and in Parkinson's disease.
Gjessing LR; Gjesdahl P; Dietrichson P; Presthus J
Eur Neurol; 1974; 12(1):33-7. PubMed ID: 4413508
[No Abstract] [Full Text] [Related]
14. Neurotransmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease.
Jiménez-Jiménez FJ; Molina JA; Vargas C; Gómez P; Navarro JA; Benito-León J; Ortí-Pareja M; Gasalla T; Cisneros E; Arenas J
J Neurol Sci; 1996 Sep; 141(1-2):39-44. PubMed ID: 8880690
[TBL] [Abstract][Full Text] [Related]
15. [Free amino acids in blood and cerebrospinal fluid in Parkinson's disease].
TORRE M; SCARZELLA R; ZANALDA A
Minerva Med; 1953 Jul; 44(59-60):256. PubMed ID: 13110848
[No Abstract] [Full Text] [Related]
16. Medical management of levodopa-associated motor complications in patients with Parkinson's disease.
Jankovic J; Stacy M
CNS Drugs; 2007; 21(8):677-92. PubMed ID: 17630819
[TBL] [Abstract][Full Text] [Related]
17. Amino acid abnormalities in cerebrospinal fluid of patients with parkinsonism and extrapyramidal disorders.
Lakke JP; Teelken AW
Neurology; 1976 May; 26(5):489-93. PubMed ID: 944400
[TBL] [Abstract][Full Text] [Related]
18. Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?
Wienecke M; Werth E; Poryazova R; Baumann-Vogel H; Bassetti CL; Weller M; Waldvogel D; Storch A; Baumann CR
J Sleep Res; 2012 Dec; 21(6):710-7. PubMed ID: 22747735
[TBL] [Abstract][Full Text] [Related]
19. Normal cerebrospinal fluid levels of insulin in patients with Parkinson's disease.
Jiménez-Jiménez FJ; Molina JA; Vargas C; Gómez P; De Bustos F; Zurdo M; Gómez-Escalonilla C; Barcenilla B; Berbel A; Camacho A; Arenas J
J Neural Transm (Vienna); 2000; 107(4):445-9. PubMed ID: 11215755
[TBL] [Abstract][Full Text] [Related]
20. Species fractionation in a case-control study concerning Parkinson's disease: Cu-amino acids discriminate CSF of PD from controls.
Willkommen D; Lucio M; Schmitt-Kopplin P; Gazzaz M; Schroeter M; Sigaroudi A; Michalke B
J Trace Elem Med Biol; 2018 Sep; 49():164-170. PubMed ID: 29472131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
